There’s a lot of talk in the health IT space about getting patients actively engaged in health care, and a lot of companies are trying to do it through mobile apps. Medfusion, a health software company that already has a... Read more »
Though Michigan’s startup community has experienced a ton of growth in the past 10 years, the state remains a place that is “underserved” when it comes to investment capital, says Chris Rizik, CEO and fund manager at Renaissance Venture Capital.... Read more »
Several years ago, Genzyme developed a drug called plerixafor (Mozobil) that’s used to help with bone marrow transplants. Now a group of folks that helped push that drug forward have reunited for a new effort—to use a similar type of therapy... Read more »
Apttus, a San Mateo, CA-based sales support provider that had already raised $41 million in February, just topped that by closing a $108 million Series C financing, the company announced today. The new funding places Apttus’ valuation at more than... Read more »
[Updated 9/2/15 8:54 am. See below.] In 2013, Cellular Dynamics vowed to create induced pluripotent stem (iPS) cell lines from the cells of 3,000 donors—some healthy, some diseased—as part of a $32 million initiative funded by the California Institute... Read more »
Looking to take some of the fees out of sending money overseas, TransferWise is firing up its New York team for its U.S. expansion.
The London-based company says it is a lower-cost option—compared with banks and other incumbent money transfer businesses—that... Read more »
Former Genzyme CEO Henri Termeer has been active as an advisor and investor in the Boston biotech scene the past few years, forming ties with companies like Moderna Therapeutics, Lysosomal Therapeutics, Aura Biosciences, and others. The latest startup to... Read more »
Addressing the needs of a climate-changing world seems like an important cause, but many cleantech startups that are developing sustainable products face an intractable challenge.
Producing a “green” alternative for an industry already using petroleum-based raw materials usually requires selling a... Read more »
For certain parts of the population, “summer” is a verb, and in the U.S., one does it until Labor Day. One more week, then, before sunburned financial types return to their desks and biotech IPO hopefuls hit the road to plead... Read more »